Profil

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.

Personál20192020202120222023
Počet zaměstnanců na konci roku11 80013 60014 40017 00018 000
Staff turnover in EUR1 760 2221 685 9841 768 7251 482 5051 398 748
Turnover LabelEUREUREUREUREUR
Akcie denominované v EUR20192020202120222023
Počet vydaných akcií (v milionech)1,001,001,001 245,851,00
Dividenda na akcii2.522.722.842.923
Zisk na akcii bez emise nových akcií4,220,104,933,644,50
Přehled zisků a ztrát v milionech EUR dle IAS/IFRS20192020202120222023
Obrat22 322,024 642,027 372,027 085,027 058,0
Provozní zisk (EBIT)5 727,22 468,68 634,16 279,96 910,8
Zisk před zdaněním (EBT)5 160,01 669,08 278,05 814,06 859,0
Annual net profit/ loss5 386,0123,06 225,04 592,05 664,0
Rozvaha v milionech EUR IAS/IFRS20192020202120222023
Aktiva
Celková běžná aktiva30 296,015 996,014 772,014 443,016 085,0
Celková fixní aktiva31 331,052 411,053 180,048 728,046 040,0
Celková aktiva61 627,068 407,067 952,063 171,062 125,0
Závazky
Celkové krátkodobé závazky9 759,011 397,011 610,011 237,011 280,0
Celkové dlouhodobé závazky29 218,038 789,035 278,030 725,028 096,0
Oprávky celkem0,00,00,00,00,0
Základní kapitál22 650,018 221,021 064,021 209,022 749,0
Celkové závazky61 627,068 407,067 952,063 171,062 125,0
Management:
Jacqueline Barton
Jeffrey Bluestone
Sandra Horning
Ted Love
Anthony Welters
Harish M. Manwani
Javier Rodriguez
Kelly Kramer
Daniel O'Day
Andrew Dickinson
Deborah H. Telman
Flavius Martin
Johanna Mercier
Jyoti Mehra
MD, PhD Merdad Parsey
Stacey Ma
Představenstvo:
Struktura akcionářů v %:
Arrowstreet Capital LP 0,67
Capital Research & Management Co. (Global Investors) 4,79
Capital Research & Management Co. (World Investors) 6,69
Dodge & Cox 2,67
Fidelity Management & Research Co. LLC 1,08
Geode Capital Management LLC 2,03
Norges Bank Investment Management 1,29
Northern Trust Investments, Inc.(Investment Management) 1,03
SSgA Funds Management, Inc. 4,78
Wellington Management Co. LLP 1,50
Streubesitz 73,47
Adresa: 333 Lakeside Drive, 94404 Foster City
T: +1-650-574-3000
F: +1-650-522-5853
I: http://www.gilead.com
E: